PMID- 34279736 OWN - NLM STAT- MEDLINE DCOM- 20220203 LR - 20220203 IS - 1432-2013 (Electronic) IS - 0031-6768 (Print) IS - 0031-6768 (Linking) VI - 473 IP - 8 DP - 2021 Aug TI - Presynaptic GABA(B) receptor-mediated network excitation in the medial prefrontal cortex of Tsc2(+/-) mice. PG - 1261-1271 LID - 10.1007/s00424-021-02576-5 [doi] AB - The TSC1 and TSC2 tumor suppressor genes control the activity of mechanistic target of rapamycin (mTOR) pathway. Elevated activity of this pathway in Tsc2(+/-) mouse model leads to reduction of postsynaptic GABA(B) receptor-mediated inhibition and hyperexcitability in the medial prefrontal cortex (mPFC). In this study, we asked whether presynaptic GABA(B) receptors (GABA(B)Rs) can compensate this shift of hyperexcitability. Experiments were performed in brain slices from adolescent wild-type (WT) and Tsc2(+/-) mice. Miniature and spontaneous postsynaptic currents (m/sPSCs) were recorded from layer 2/3 pyramidal neurons in mPFC using patch-clamp technique using a Cs(+)-based intrapipette solution. Presynaptic GABA(B)Rs were activated by baclofen (10 microM) or blocked by CGP55845 (1 microM). Independent on genotype, GABA(B)R modulators bidirectionally change miniature excitatory postsynaptic current (mEPSC) frequency by about 10%, indicating presynaptic GABA(B)R-mediated effects on glutamatergic transmission are comparable in both genotypes. In contrast, frequencies of both mIPSCs and sIPCSs were suppressed by baclofen stronger in Tsc2(+/-) neurons than in WT ones, whereas CGP55845 significantly increased (m/s)IPSC frequencies only in WT cells. Effects of baclofen and CGP55845 on the amplitudes of evoked (e)IPSCs confirmed these observations. These data indicate (1) that GABAergic synapses are inhibited by ambient GABA in WT but not in Tsc2(+/-) slices, and (2) that baclofen shifts the E/I ratio, determined as the ratio of (m/s)EPSC frequency to (m/s)IPSC frequency, towards excitation only in Tsc2(+/-) cells. This excitatory presynaptic GABA(B)R-mediated action has to be taken into account for a possible medication of mental disorders using baclofen. CI - (c) 2021. The Author(s). FAU - Bassetti, Davide AU - Bassetti D AUID- ORCID: 0000-0003-1350-4390 AD - Institute of Physiology, University Medical Center of the Johannes Gutenberg University Mainz, Duesbergweg 6, 55128, Mainz, Germany. dbassett@uni-mainz.de. FAU - Luhmann, Heiko J AU - Luhmann HJ AD - Institute of Physiology, University Medical Center of the Johannes Gutenberg University Mainz, Duesbergweg 6, 55128, Mainz, Germany. FAU - Kirischuk, Sergei AU - Kirischuk S AD - Institute of Physiology, University Medical Center of the Johannes Gutenberg University Mainz, Duesbergweg 6, 55128, Mainz, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210719 PL - Germany TA - Pflugers Arch JT - Pflugers Archiv : European journal of physiology JID - 0154720 RN - 0 (Receptors, GABA-B) RN - 0 (Tsc2 protein, mouse) RN - 0 (Tuberous Sclerosis Complex 2 Protein) SB - IM MH - Animals MH - GABAergic Neurons/*metabolism MH - Mice MH - Patch-Clamp Techniques MH - Prefrontal Cortex/*metabolism MH - Presynaptic Terminals/*metabolism MH - Receptors, GABA-B/*metabolism MH - Tuberous Sclerosis Complex 2 Protein/genetics PMC - PMC8302497 OTO - NOTNLM OT - Autistic spectrum disorder OT - E/I ratio OT - Hyperexcitability OT - MTOR OT - Presynaptic tonic inhibition COIS- The authors declare no competing interests. EDAT- 2021/07/20 06:00 MHDA- 2022/02/04 06:00 PMCR- 2021/07/19 CRDT- 2021/07/19 13:02 PHST- 2021/03/03 00:00 [received] PHST- 2021/05/05 00:00 [accepted] PHST- 2021/04/21 00:00 [revised] PHST- 2021/07/20 06:00 [pubmed] PHST- 2022/02/04 06:00 [medline] PHST- 2021/07/19 13:02 [entrez] PHST- 2021/07/19 00:00 [pmc-release] AID - 10.1007/s00424-021-02576-5 [pii] AID - 2576 [pii] AID - 10.1007/s00424-021-02576-5 [doi] PST - ppublish SO - Pflugers Arch. 2021 Aug;473(8):1261-1271. doi: 10.1007/s00424-021-02576-5. Epub 2021 Jul 19.